US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist

54.390
+0.400+0.74%

Close Nov 1 16:00 ET

54.390
0.0000.00%

Post 20:02 ET

2.84BMarket Cap-61806P/E (TTM)

Janux Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Janux Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 1.600M	--
--	2024/Q3	-- / 1.645M	--
--	2024/Q2	8.897M / 863.120K	--
--	2024/Q1	1.252M / 1.018M	--
--	2023/Q4	2.461M / 739.250K	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 1.600M--

--2024/Q3-- / 1.645M--

--2024/Q28.897M / 863.120K--

--2024/Q11.252M / 1.018M--

--2023/Q42.461M / 739.250K--

Unlock Free Earnings Estimates

Open Account

Janux Therapeutics Earnings Reports

Janux Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7 22:24 ET

Janux Therapeutics | 10-Q: Q1 2024 Earnings Report

May 8 15:42 ET

Janux Therapeutics | 10-K: FY2023 Annual Report

Mar 8 16:26 ET

Janux Therapeutics | 10-Q: Q3 2023 Earnings Report

Nov 7, 2023 16:19 ET

Analyst Rating

Updated: Oct 31, 2024

Strong Buy

Buy
90.00%
Hold
10.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall